#regulatory-milestones

[ follow ]
#specialty-pharmaceuticals #oncology-pipeline #neuroscience-drugs #valuation #zelenectide-pevedotin
Business
from24/7 Wall St.
1 week ago

UBS Just Upgraded Jazz Pharma to Buy. New $307 Price Target Could Signal a Turning Point

UBS upgraded Jazz Pharmaceuticals to Buy with a $307 target, citing resilient franchises, pipeline progress, and valuation upside ahead of zanidatamab PDUFA.
Medicine
fromLondon Business News | Londonlovesbusiness.com
3 months ago

Armistice Capital increases bicycle therapeutics stake as company awaits regulatory feedback on lead drug candidate - London Business News | Londonlovesbusiness.com

Bicycle Therapeutics advanced zelenectide pevedotin development while investors increased positions ahead of upcoming regulatory feedback and pivotal trial readouts.
[ Load more ]